Heparin Investigation - Latest Baxter Update Baxter is providing an update on severaladvances related to the investigation into recent heparin adverse reactionsassociated with the company's U.S. vial-based heparin products, which havesince been recalled. I. Baxter confirms that the contaminant identified in the company'sU.S. heparin vial products is hypersulfated chondroitin sulfate. Baxter scientists have provided information to the U.S.
Source: www.medicalnewstoday.comTop Institute Pharma Has Started 42 Research Projects Totaling 260 Million Euros Eight new and highly innovative research projects are starting in the Top Institute Pharma's Strategic Research Program. Top Institute Pharma is a Dutch public-private partnership founded in 2006. Within TI Pharma, consortia of industrial and academic research teams conduct groundbreaking, cross-disciplinary research projects that fit into the Priority
Medicines program of the WHO. Each year, the Dutch government funds the top institute 30 million Euros.
Source: www.medicalnewstoday.com
# posted by Network @ 8:00 AM
